These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 392283)

  • 21. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
    Deshpande AK; Londhe VA; Akarte S; Briggs D
    J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoprophylaxis against rabies.
    Rai Chowdhuri AN; Bhatia R; Ichhpujani RL
    J Commun Dis; 1984 Mar; 16(1):43-8. PubMed ID: 12055785
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
    Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
    Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibody determination after preventive and post-exposal rabies vaccination. Retrospective study].
    Hefti J; Keller H; Geiser M; Gerber H; Wandeler A; Steck F
    Schweiz Med Wochenschr; 1979 Apr; 109(14):509-16. PubMed ID: 432584
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunogenicity study of abbreviated rabies preexposure vaccination schedules.
    Khawplod P; Wilde H; Benjavongkulchai M; Sriaroon C; Chomchey P
    J Travel Med; 2007; 14(3):173-6. PubMed ID: 17437473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies.
    Schumacher CL; Dietzschold B; Ertl HC; Niu HS; Rupprecht CE; Koprowski H
    J Clin Invest; 1989 Sep; 84(3):971-5. PubMed ID: 2760222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Human revaccination against Lyssa: efficacy of various booster schedules].
    Simona R; Keller H; Spengler G; Gerber H; Weiss M; Steck F
    Schweiz Med Wochenschr; 1979 Nov; 109(44):1702-8. PubMed ID: 524102
    [No Abstract]   [Full Text] [Related]  

  • 28. Some experiences with human diploid cell strain-(HDCS) rabies vaccine in pre- and post-exposure vaccinated humans.
    Kuwert EK; Marcus I; Werner J; Iwand A; Thraenhart O
    Dev Biol Stand; 1978; 40():79-88. PubMed ID: 680404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intradermal pre-exposure rabies vaccine elicits long lasting immunity.
    Brown D; Featherstone JJ; Fooks AR; Gettner S; Lloyd E; Schweiger M
    Vaccine; 2008 Jul; 26(31):3909-12. PubMed ID: 18547689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response to human diploid cell antirabies vaccine in human volunteers--a preliminary study.
    Bhatia R; Ichhpujani RL; Rai Chowdhuri AN
    J Commun Dis; 1984 Mar; 16(1):70-3. PubMed ID: 12055790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rabies antibody titers in vaccinees: protection, failure and prospects.
    Dutta JK; Pradhan SC; Dutta TK
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):107-12. PubMed ID: 1506120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response after a four-site intradermal booster vaccination with cell-culture rabies vaccine.
    Tantawichien T; Benjavongkulchai M; Limsuwan K; Khawplod P; Kaewchompoo W; Chomchey P; Sitprija V
    Clin Infect Dis; 1999 May; 28(5):1100-3. PubMed ID: 10452642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pre-exposure rabies vaccination using a new duck embryo vaccine].
    Bachmann G; Steffen R; Glück R; Wegmann A; Schär M
    Schweiz Med Wochenschr; 1985 Jun; 115(25):863-5. PubMed ID: 4023675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibody response after a two-year intradermal booster of rabies human diploid cell vaccine.
    Horman JT; Rullán JV; Myers RA; Bond JO; Israel E; Joseph JM
    J Am Vet Med Assoc; 1987 Jul; 191(2):185-7. PubMed ID: 3610792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Post exposure use of human diploid cell culture rabies vaccine (author's transl)].
    Kuwert EK; Marcus I; Werner J; Höher PG; Thraenhart O; Hierholzer E; Iwand A; Helm EB; Wiktor TJ; Koprowski H
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):437-58. PubMed ID: 610245
    [No Abstract]   [Full Text] [Related]  

  • 36. Results of rabies post-exposure treatment with antirabies serum and the human diploid cell vaccine in Iran.
    Bahmanyar M
    Dev Biol Stand; 1978; 40():163-5. PubMed ID: 680390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on an inactivated vaccine against rabies virus in domestic animals.
    Monaco F; Franchi PM; Lelli R
    Dev Biol (Basel); 2006; 125():233-9. PubMed ID: 16878481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antirabies antibody titers without vaccination.
    Wolff A
    J Am Vet Med Assoc; 2012 Nov; 241(10):1275. PubMed ID: 23113515
    [No Abstract]   [Full Text] [Related]  

  • 39. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.